This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Conceptus(R) Names Joseph G. Sharpe As Executive Vice President Of Operations

Stocks in this article: CPTS

MOUNTAIN VIEW, Calif., Jan. 22, 2013 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS), developer of the Essure ® procedure, the leading surgery-free permanent birth control method, announced today that it has appointed operations executive Joseph G. Sharpe to the newly-created position of Executive Vice President of Operations, effective immediately. Mr. Sharpe has 25 years of experience optimizing the operations of world-class medical device companies. He will lead the Company's global operations and manufacturing efforts and report directly to Conceptus President and Chief Executive Officer, D. Keith Grossman.

Mr. Sharpe joins Conceptus from OptoVue Medical, where he served as the Senior Vice President of Operations. In this role, Mr. Sharpe managed all aspects of operations including manufacturing, supply chain, engineering, and the quality assurance functions of the company, among others. Mr. Sharpe's experience also includes eight years with Thoratec Corporation, from 1997 to 2005, where he held the position of Vice President of Operations. During his time at Thoratec, Mr. Sharpe was responsible for manufacturing, supply chain, engineering, facilities, customer service and durable equipment repair.

Prior to his tenure at Thoratec Corporation, Mr. Sharpe held numerous positions in operations with Baxter Healthcare Corporation from 1983 to 1997, with increasing scale and responsibility culminating in his role as Director of Operations from 1992 to 1997. Mr. Sharpe received a B.S. degree in mechanical engineering from the University of Massachusetts at Lowell in 1981.

Costa Rica Manufacturing

After an extensive evaluation of potential manufacturing locations, Conceptus has decided to internalize future manufacturing expansion of Essure with operations in Costa Rica. The company believes that Costa Rica offers favorable labor rates, low tax rates and an experienced pool of employees that are skilled in medical device manufacturing.  Conceptus Costa Rica S.R.L., the company's subsidiary, expects to install a production line and begin validation in the second half of 2013 in preparation for an FDA regulatory submission in the first half of 2014. Conceptus expects that once the plant is operational, product manufacturing costs will be significantly lower than current outsourced production costs.   

1 of 3

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,612.94 +256.07 1.48%
S&P 500 2,039.88 +26.99 1.34%
NASDAQ 4,706.6420 +62.33 1.34%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs